UCLA has received $27.2 million from the National Institutes of Health to spearhead the new phase of an initiative to enhance the diversity of the U.S.'s biomedical workforce. Principal investigators of the initiative include Fielding School professors Teresa Seeman and Steven Wallace, as well as senior leader Catherine Crespi.

Thiazide diuretics demonstrate better effectiveness and cause fewer side effects than ACE inhibitors as first-line antihypertensive drugs, according to a report led by Fielding School professor of biostatistics Marc Suchard. The report was published in The Lancet.

Sweeping changes designed to make the food more nutritious in a federal assistance program for low-income families reduced the risk for obesity for 4-year-olds who had been on the program since birth, according to new research.

The six-year-long study about endocrine treatment was co-authored by FSPH professors Dr. Patricia Ganz and Catherine Crespi.

UCLA Fielding School of Public Health faculty members Ronald Hays, Steve Horvath, Michael Jerrett, André Nel, Beate Ritz and Marc Suchard have been named to Clarivate Analytics' annual list of highly cited researchers.

Ronald S. Brookmeyer, UCLA Fielding School of Public Health professor of biostatistics, has been appointed interim dean of the Fielding School. He will begin his term on November 1, 2018.

In March 2018, the National Institute on Drug Abuse (NIDA) awarded researchers at the UCLA Fielding School of Public Health $9.5 million over five years to continue their work on possible connections between substance abuse and HIV infection. The work, which has officially begun this June, is a continuation of a study that launched in 2013 with a $7 million NIDA grant.

UCLA Fielding School of Public Health researchers determine risks based on age, gender and biomarker screening.

As accelerated aging of different parts of women’s bodies comes to light, new questions are raised about hormone exposure and breast cancer risk.